Published in J Virol on January 01, 2004
Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res (2010) 2.26
Molecular virology of hepatitis E virus. Virus Res (2011) 1.80
Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A (2009) 1.71
The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol (2005) 1.50
Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol (2007) 1.16
NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain. J Virol (2010) 1.13
Cross-species infection of pigs with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States. J Gen Virol (2012) 1.09
Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect (2012) 0.97
Hepatitis E: a complex and global disease. Emerg Health Threats J (2008) 0.89
Intergenotypic chimeric hepatitis E viruses (HEVs) with the genotype 4 human HEV capsid gene in the backbone of genotype 3 swine HEV are infectious in pigs. Virus Res (2010) 0.87
An essential RNA element resides in a central region of hepatitis E virus ORF2. J Gen Virol (2013) 0.87
Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation. J Virol (2011) 0.85
Hepatitis e: molecular virology and pathogenesis. J Clin Exp Hepatol (2013) 0.80
Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoS Pathog (2016) 0.79
Role of Envelopment in the HEV Life Cycle. Viruses (2016) 0.78
Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses. J Virol (2012) 0.78
Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins. Sci Rep (2016) 0.77
Development of a novel enzyme-linked immunosorbent assay to detect anti-IgG against swine hepatitis E virus. J Vet Sci (2013) 0.76
Therapeutic targets for the treatment of hepatitis E virus infection. Expert Opin Ther Targets (2015) 0.75
Molecular Biology and Infection of Hepatitis E Virus. Front Microbiol (2016) 0.75
Hepatobiliary quiz-7 (2013). J Clin Exp Hepatol (2013) 0.75
Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol (1983) 12.99
Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology (1991) 6.38
A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci U S A (1996) 4.44
A conserved RNA-binding protein that regulates sexual fates in the C. elegans hermaphrodite germ line. Nature (1997) 4.34
Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med (1980) 3.94
Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A (1992) 3.24
Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology (1992) 2.92
Incidence and severity of viral hepatitis in pregnancy. Am J Med (1981) 2.76
Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A (1992) 2.64
The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol (1997) 2.39
Enterically-transmitted non-A, non-B hepatitis. Br Med Bull (1990) 2.28
The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein. EMBO J (1997) 2.19
Mutagenesis of the conserved 51-nucleotide region of Sindbis virus. J Virol (1990) 2.02
Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res (1992) 1.89
The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem (2001) 1.82
Expression in animal cells and characterization of the hepatitis E virus structural proteins. J Virol (1996) 1.74
The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem (2002) 1.52
The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol (2000) 1.40
Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol (1993) 1.32
Epitope mapping in proteins of hepatitis E virus. Virology (1993) 1.25
Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology (1994) 1.22
Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J Clin Microbiol (1994) 1.22
Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells. J Gen Virol (1999) 1.16
Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl (1993) 1.14
Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch Virol (2000) 1.10
Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein. J Virol (2001) 0.94
Combined transformation and genetic technique verification of protein-protein interactions in the yeast two-hybrid system. Biochem Biophys Res Commun (2000) 0.86
Expression and characterization of the hepatitis E virus ORF3 protein in the methylotrophic yeast, Pichia pastoris. Gene (1997) 0.85
A yeast two-hybrid study on self-association of the ORF2 protein of hepatitis E virus. Biochem Biophys Res Commun (2001) 0.83
The liver-specific human alpha(1)-microglobulin/bikunin precursor (AMBP) is capable of self-association. Arch Biochem Biophys (2002) 0.80
A liquid synchronized-growth culture assay for the identification of true positive and negative yeast three-hybrid transformants. Lett Appl Microbiol (2002) 0.78
Molecular biology and pathogenesis of hepatitis E virus. J Biosci (2008) 1.85
Hepatitis E. Hepatology (2011) 1.84
Molecular virology of hepatitis E virus. Virus Res (2011) 1.80
The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem (2002) 1.52
The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J Biol Chem (2004) 1.41
Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists. Am J Gastroenterol (2002) 1.33
The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem (2004) 1.24
The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol (2005) 1.20
Biology of the HIV Nef protein. Indian J Med Res (2005) 1.20
The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem (2006) 1.19
The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem J (2004) 1.16
The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. Biochem Biophys Res Commun (2004) 1.16
The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation. J Virol (2005) 1.15
The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol (2008) 1.15
Molecular virology of hepatitis E virus. Semin Liver Dis (2013) 1.12
Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol (2009) 1.12
An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses. J Virol (2010) 1.12
Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. J Med Virol (2008) 1.10
Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res (2003) 1.09
Enhanced alpha1 microglobulin secretion from Hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. J Biol Chem (2006) 1.08
The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem (2007) 1.07
The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell Microbiol (2009) 1.06
The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One (2009) 1.06
Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol (2007) 1.06
The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor. J Virol (2005) 1.04
Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol (2006) 1.04
Glycogen synthase kinase-3 phosphorylates and regulates the stability of p27kip1 protein. Cell Cycle (2007) 1.04
Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif. J Biol Chem (2005) 1.04
Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol (2007) 1.03
Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation. J Virol (2007) 1.03
Hepatitis E vaccine. Hepatol Int (2008) 1.01
In silico analysis of genes nucleoprotein, neuraminidase and hemagglutinin: a comparative study on different strains of influenza A (Bird flu) virus sub-type H5N1. In Silico Biol (2006) 1.00
PCNA interacts with Indian mung bean yellow mosaic virus rep and downregulates Rep activity. J Virol (2004) 0.97
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF. Proteome Sci (2011) 0.97
The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II. Biochemistry (2008) 0.95
The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference. PLoS One (2013) 0.94
The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol (2010) 0.94
Influenza virus and cell signaling pathways. Med Sci Monit (2011) 0.93
Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS One (2011) 0.92
Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem Biophys Res Commun (2004) 0.92
Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae. Protein Expr Purif (2003) 0.91
The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem (2012) 0.90
Adaptive immune responses during acute uncomplicated and fulminant hepatitis E. J Gastroenterol Hepatol (2011) 0.90
HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol (2009) 0.89
Ribozymes: a modern tool in medicine. J Biomed Sci (2003) 0.89
Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein--a genetic, biochemical and biophysical analysis. Virol J (2007) 0.89
A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host Microbe (2007) 0.89
The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4. PLoS One (2011) 0.89
A C-Terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) Protein. J Biomed Biotechnol (2001) 0.89
The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol (2007) 0.89
Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus. Bioinformation (2006) 0.88
The molecular biology of SARS coronavirus. Ann N Y Acad Sci (2007) 0.88
Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol J (2006) 0.88
Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol (2008) 0.87
Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci (2009) 0.87
Consensus proposals for classification of the family Hepeviridae. J Gen Virol (2015) 0.87
The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. Virology (2007) 0.86
HIV-1 Nef induces a Rab11-dependent routing of endocytosed immune costimulatory proteins CD80 and CD86 to the Golgi. Traffic (2008) 0.86
The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor. J Virol (2010) 0.86
Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α-actinin-4 for viral replication. FEBS J (2014) 0.86
Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages. Virol J (2007) 0.85
ORF3 protein of hepatitis E virus interacts with the Bbeta chain of fibrinogen resulting in decreased fibrinogen secretion from HuH-7 cells. J Gen Virol (2009) 0.85
Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy. PLoS One (2013) 0.84
Virus entry paradigms. Amino Acids (2009) 0.84
Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein. J Biol Chem (2012) 0.83
Hepatitis E virus genotype 1, Cuba. Emerg Infect Dis (2008) 0.82
Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin. J Gen Virol (2007) 0.82
Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic (2015) 0.82
Functional genomics as a tool in virus research. Indian J Microbiol (2008) 0.82
SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus. PLoS One (2011) 0.81
A new panel of NS1 antibodies for easy detection and titration of influenza A virus. J Med Virol (2010) 0.81
The 3a accessory protein of SARS coronavirus specifically interacts with the 5'UTR of its genomic RNA, Using a unique 75 amino acid interaction domain. Biochemistry (2007) 0.81
Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach. Indian J Microbiol (2010) 0.81
Pandemic flu: from the front lines. Interviewed by Declan Butler. Nature (2009) 0.80
The liver-specific human alpha(1)-microglobulin/bikunin precursor (AMBP) is capable of self-association. Arch Biochem Biophys (2002) 0.80
Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma. World J Gastroenterol (2006) 0.80
SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways. Biochemistry (2011) 0.79
Interplay between influenza A virus and host factors: targets for antiviral intervention. Arch Virol (2015) 0.78
Universal precautions guideline: self-reported compliance by gastroenterologists and gastrointestinal endoscopy nurses--a decade's lack of progress. Am J Gastroenterol (2003) 0.78
Inhibition of N-terminal lysines acetylation and transcription factor assembly by epirubicin induced deranged cell homeostasis. PLoS One (2012) 0.78
H7N9: A killer in the making or a false alarm? Can J Microbiol (2014) 0.78
Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology (2010) 0.78
Hepatitis E viruses. Foreword. Virus Res (2011) 0.77
Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. J Clin Virol (2008) 0.77
Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers. PLoS One (2013) 0.77
Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice. Appl Biochem Biotechnol (2014) 0.76
Recombinant haemagglutinin protein of highly pathogenic avian influenza A (H5N1) virus expressed in Pichia pastoris elicits a neutralizing antibody response in mice. J Virol Methods (2012) 0.76
SARS coronavirus 3b accessory protein modulates transcriptional activity of RUNX1b. PLoS One (2012) 0.76
Effect of mitoxantrone on proliferation dynamics and cell-cycle progression. Biosci Rep (2010) 0.76
LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells. Cell Biol Int (2014) 0.76
Putting T cells to sleep: a new paradigm for immune evasion by persistent viruses. J Biosci (2006) 0.76
Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris. J Biosci (2014) 0.75
Molecular events leading to the creation of a pandemic influenza virus. Indian J Microbiol (2010) 0.75
The birds are coming: are we ready? Indian J Med Res (2005) 0.75
A yeast assay for high throughput screening of natural anti-viral agents. Biochem Biophys Res Commun (2003) 0.75
Hepatitis E virus in bottlenose dolphins Tursiops truncatus. Dis Aquat Organ (2017) 0.75